The global embryo incubator market achieved a valuation of approximately USD 77.8 million in 2022. In 2023, this market is projected to grow to an estimated USD 81.2 million, reflecting the increasing need for advanced reproductive technologies.
According to Future Market Insights (FMI), the global embryo incubator market is anticipated to reach USD 137.7 million by 2033, registering a compound annual growth rate (CAGR) of 5.4% from 2023 to 2033. This growth can be attributed to the rising incidence of in-vitro fertilization (IVF) techniques among patients seeking assistance with reproduction.
Embryo incubation plays a crucial role in the medical field, particularly in the context of assisted reproductive technologies. The process of embryo transfer, which involves implanting an embryo into a woman’s uterus in preparation for pregnancy, is a key application of embryo incubators. This technique is used for both human and animal reproductive health.
Key Growth Drivers:
- Increasing demand for IVF procedures: As more individuals and couples seek assistance with conception, the demand for reliable embryo incubation technologies continues to rise.
- Advancements in reproductive technology: Innovations in embryo incubation techniques are enhancing the success rates of assisted reproductive procedures.
- Growing awareness and acceptance of assisted reproductive technologies: As society becomes more open to discussing and utilizing reproductive health solutions, the market for embryo incubators is expected to expand.
The embryo incubator market is positioned for significant growth as healthcare providers continue to adopt advanced technologies to support reproductive health. This trend not only enhances the success of fertility treatments but also improves the overall patient experience.
Embryo incubation plays a pivotal role in the medical industry, particularly in the field of assisted reproductive technologies. The embryo, being the first stage of a new creature’s development, necessitates precise and advanced incubation methods. The groundbreaking procedure of embryo transfer, involving the implantation of an embryo into a woman’s uterus to prepare her for pregnancy, has become a cornerstone in both animal and human reproductive health.
Embryos used for pregnancy can be fresh or frozen for many years; frozen embryos can be nursed within incubators for many years under original conditions, with suitable temperature, nutritional medium provided to keep the embryo alive, adequate humidity, and other elements to support the embryo.
Global Embryo Incubator Industry: Drivers and Restraints
Embryo Incubator is growing market as, the number of fertilization problem is increasing over globe due to lifestyle disorder. The IVF (in vitro fertilization) helping the peoples who are dreaming for family with babies. According to CDC (Centers for Disease Control), in U.S approximately ~4 million births occurs per year from that 1 and 2 percent birth occurs due to IVF (in vitro fertilization), which directly fuel the market of Embryo Incubator in US and another fact with directly increase the demand Embryo Incubators is that 5 million babies over the globe are due to IVF (in vitro fertilization) according to ESHRE (European Society of Human Reproduction and Embryology). The high price and lack of awareness in healthcare professional to handle the embryo in the incubator is the current hindrances for the Embryo Incubator market.
Global Embryo Incubator Industry: Overview
Embryo Incubator is high in demand in various region over the globe, as the new born babies in the region are from IVF (in vitro fertilization). Now a day’s majority of the populations are going for IVF (in vitro fertilization) due to lifestyle disorders and improper diets. Players are focusing new innovative technology to enhance the incubators to show more quality to improve embryo mentioning, which should be increase by providing proper temperature and perfect pH balance along with original essential gases in proper amount.
Embryo Incubator Industry: Region-wise Outlook
Geographically, Embryo Incubator market is segmented into North America, Latin America, Western Europe, Eastern Europe, Asia Pacific, Japan, Middle East and Africa. North America show major market share in Embryo Incubator, due to the high present of players in the region and highly acceptation of IVF (in vitro fertilization). Europe show the perfect market for growth of Embryo Incubator as the players are coming with more product in the region. Asia Pacific is a growing market as the awareness is increasing in healthcare professional to use the Embryo Incubator for IVF (in vitro fertilization). MEA is the region which is in introductory phase as the medical system and others are supporting and focusing on the use of Embryo Incubator for medical use.
Global Embryo Incubator Industry: Key Players
Some of the players in Embryo Incubator market include: Esco Micro Pte. Ltd., Vitrolife, Genea Biomedx, Cook Medical Inc., Thermo Fisher Scientific Inc., Genea Limited, EMD Sereno Inc. (sub. Merck KGaA), IVFtech ApS and The Baker Company.
Global Embryo Incubator Industry Recent Development:
- In May 2022, The MINC+TM Benchtop Incubator has been launched by Cook Medical, specifically for IVF facilities in the United States and Canada.
- In May 2022, Cook Medical is committed to enhancing people’s lives, not only through patient care but also in the communities it serves. In line with this commitment, Cook Medical’s manufacturing plant in Winston-Salem has recently achieved the ISO 14001 certification, which is the internationally recognized standard for environmental management systems.
Global Embryo Incubator Industry: Segmentation
Global Embryo Incubator Industry is segmented by
Embryo Incubator by Product Type
- Tri-gas Incubators
- Tri-gas Incubators with Camera
Embryo Incubator by End User
- Hospital and research laboratories
- Fertility clinics
- Cryobank
Author
Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.
Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.
Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube
